INFECTIOUS DISEASES INSTITUTE
Showing 241-250 of 516 items.
| # | Activity Title | CPD Provider | Start Date | Event Time | Location | Cost (UGX) | CPD Points | End Date | Status | Details |
|---|---|---|---|---|---|---|---|---|---|---|
| 241 | Case Conference | INFECTIOUS DISEASES INSTITUTE | May 31, 2024 | 10:00 AM | Hybrid | 0 | 1 | May 31, 2024 | Closed | Read More |
| 242 | Switch Meeting | INFECTIOUS DISEASES INSTITUTE | May 31, 2024 | 10:00 AM | Hybrid | 0 | 1 | May 31, 2024 | Closed | Read More |
| 243 | Job Harzard risk assessment analysis | INFECTIOUS DISEASES INSTITUTE | May 31, 2024 | 09:45 AM | Training Room 2&3 | 0 | 2 | May 31, 2024 | Closed | Read More |
| 244 | Journal Club | INFECTIOUS DISEASES INSTITUTE | May 31, 2024 | 09:45 AM | Hybrid | 0 | 1 | May 31, 2024 | Closed | Read More |
| 245 | PCT General Staff Meeting | INFECTIOUS DISEASES INSTITUTE | May 31, 2024 | 09:45 AM | Training Room 2&3 | 0 | 2 | May 31, 2024 | Closed | Read More |
| 246 | KHP Performance Review Meeting | INFECTIOUS DISEASES INSTITUTE | May 31, 2024 | 09:30 AM | Training Room 2&3 | 0 | 2 | May 31, 2024 | Closed | Read More |
| 247 | IPC Meeting | INFECTIOUS DISEASES INSTITUTE | May 31, 2024 | 09:30 AM | Board Room | 0 | 2 | May 31, 2024 | Closed | Read More |
| 248 | Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts | INFECTIOUS DISEASES INSTITUTE | May 28, 2024 | 09:45 AM | Hybrid | 0 | 1 | May 28, 2024 | Closed | Read More |
| 249 | Motarity Audit | INFECTIOUS DISEASES INSTITUTE | May 28, 2024 | 08:00 AM | ZOOM | 0 | 3 | May 28, 2024 | Closed | Read More |
| 250 | Nurses as our IPC Champions | INFECTIOUS DISEASES INSTITUTE | May 9, 2024 | 01:15 PM | Virtual | 0 | 1 | May 9, 2024 | Closed | Read More |